SOPYX
Price
$33.55
Change
+$0.30 (+0.90%)
Updated
Dec 3 closing price
Net Assets
8.94B
VVIAX
Price
$74.33
Change
+$0.66 (+0.90%)
Updated
Dec 3 closing price
Net Assets
207.95B
Interact to see
Advertisement

SOPYX vs VVIAX

Header iconSOPYX vs VVIAX Comparison
Open Charts SOPYX vs VVIAXBanner chart's image
ClearBridge Dividend Strategy I
Price$33.55
Change+$0.30 (+0.90%)
VolumeN/A
Net Assets8.94B
Vanguard Value Index Adm
Price$74.33
Change+$0.66 (+0.90%)
VolumeN/A
Net Assets207.95B
SOPYX vs VVIAX Comparison Chart in %
View a ticker or compare two or three
VS
SOPYX vs. VVIAX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SOPYX is a Buy and VVIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 208B vs. SOPYX (8.94B). VVIAX pays higher dividends than SOPYX: VVIAX (2.04) vs SOPYX (1.27). SOPYX was incepted earlier than VVIAX: SOPYX (30 years) vs VVIAX (25 years). SOPYX (0.73) is less costly to investors than VVIAX (0.05). SOPYX is a more actively managed with annual turnover of: 19.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than SOPYX: VVIAX (3000) vs SOPYX (1000000). VVIAX annual gain was more profitable for investors over the last year : 6.10 vs. SOPYX (-1.06). VVIAX return over 5 years is better than : 60.40 vs. SOPYX (30.98).
SOPYXVVIAXSOPYX / VVIAX
Total Expense Ratio0.730.051,460%
Annual Report Gross Expense Ratio0.730.051,460%
Fund Existence30 years25 years-
Gain YTD9.67212.64077%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets8.94B208B4%
Annual Yield % from dividends1.272.0462%
Returns for 1 year-1.066.10-17%
Returns for 3 years18.1230.8259%
Returns for 5 years30.9860.4051%
Returns for 10 years87.90128.9068%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALLO1.520.18
+13.43%
Allogene Therapeutics
BCAB0.830.05
+6.00%
BioAtla
AGIO27.490.51
+1.89%
Agios Pharmaceuticals
WTGUU10.30N/A
N/A
Wintergreen Acquisition Corp.
UGI37.64-0.49
-1.29%
UGI Corp